Prognostic factors in thymic epithelial neoplasms

Eur J Cardiothorac Surg. 2002 Feb;21(2):307-13. doi: 10.1016/s1010-7940(01)01091-0.

Abstract

Objectives: The primary thymic epithelial neoplasms (PTENs) are uncommon tumours with a broad spectrum of both biological and morphological features. The aim of this study is to analyse the prognostic factors that influence survival.

Methods: Forty-four patients with a complete follow-up were analysed. Nine patients (20.5%) were asymptomatic, the most common symptoms in the rest being myasthenia gravis and dyspnoea. All the patients underwent surgery, 30 cases (68.2%) receiving total thymectomy and the rest a partial resection or biopsy. Marino-Müller's histological classification showed the mixed type to be the most common (52.3%). Clinical staging was done according to the Masaoka classification, which gave the most common stage as stage III (34.1%).

Results: Twelve patients died during a mean follow-up of 8.2 +/- 3.5 years. The accumulated survival rate was 77% at 5 years and 60% at 10 years. Analysis of the survival curves shows significant differences (P<0.05) when considering surgical technique, clinical staging and histological subtype. The multivariate analysis shows the only parameters with prognostic significance in PTENs to be clinical staging and histological type (P<0.001).

Conclusions: The most important prognostic factors in PTENs are Masaoka's clinical staging and Marino-Müller's histological subtype.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biopsy, Needle
  • Carcinoma / mortality
  • Carcinoma / pathology*
  • Carcinoma / surgery*
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Probability
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Survival Rate
  • Thymectomy / methods
  • Thymoma / mortality
  • Thymoma / pathology*
  • Thymoma / surgery*
  • Thymus Neoplasms / mortality
  • Thymus Neoplasms / pathology*
  • Thymus Neoplasms / surgery*
  • Treatment Outcome